A polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia

American Journal of Physiology. Heart and Circulatory Physiology
Isaac GeorgeJie Wang

Abstract

The purpose of this study was to test if HBOC-201, a hemoglobin-based oxygen-carrying solution, can decrease infarct size (or Inf) during acute, severe myocardial ischemia and reperfusion. To test the impact of HBOC-201 on infarct size, ischemia was produced in 18 dogs by coronary stenosis to achieve 80-95% flow reduction for 195 min along with pacing 10% above the spontaneous heart rate, followed by 180 min of reperfusion. Animals were randomized to intravenous infusion of HBOC-201 (1 g/kg) (n=6), normal saline (NS) (n=6), or phenylephrine (Phe) (n=6, as a control for the increased blood pressure seen with HBOC-201), given 15 min after the start of ischemia. Amount of infarct was quantified as the ratio between area at risk (AAR) and Inf after Evans blue and 2,3,5-triphenyltetrazolium chloride staining. Hearts were divided into five layers from base (layer A) to apex (layer E) and photographed for digital image analysis of AAR and Inf. Regional myocardial function (RMF) was also measured after 60 min of ischemia and 15 min of reperfusion. Inf/AAR was significantly reduced after HBOC-201 therapy (4.4+/-2.2%) vs. NS (26.0+/-3.6%) and Phe (25.7+/-4.1%) (both, P<0.05). RMF after reperfusion was restored to 92% of baseline with HBO...Continue Reading

References

Oct 16, 1980·The New England Journal of Medicine·M A DeWoodH T Lang
Oct 1, 1995·Clinical Pharmacology and Therapeutics·G S HughesE E Jacobs
Jan 1, 1997·The Journal of Clinical Investigation·M T HenekaH Osswald
Feb 15, 2001·The Journal of Thoracic and Cardiovascular Surgery·K SuehiroD Burkhoff
Apr 9, 2001·Journal of Cardiovascular Electrophysiology·R J Myerburg
Jul 24, 2004·Circulation Research·Roberto BolliUNKNOWN NHLBI Working Group on the Translation of Therapies for Protecting the Heart from Ischemia
Mar 18, 2005·American Journal of Physiology. Heart and Circulatory Physiology·John E CaswellDavid J Lefer

❮ Previous
Next ❯

Citations

Aug 8, 2009·Antioxidants & Redox Signaling·Paul W Buehler, Felice D'Agnillo
Apr 28, 2009·American Journal of Respiratory Cell and Molecular Biology·David IrwinRobert W Gotshall
Jun 8, 2013·World Journal of Gastroenterology : WJG·Abdulrahman K Al AsmariSaeed Al Asmary
Mar 1, 2008·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Patrick W SerruysJanette Symons
Dec 31, 2008·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Emanuele MeligaPatrick W Serruys
Dec 31, 2008·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Gregory P DubéA Gerson Greenburg
Oct 16, 2007·Cancer Treatment Reviews·Minghua YuRuijuan Xiu
Nov 10, 2011·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Tao LiChengmin Yang
Mar 22, 2012·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Jianqun HanQian Liu
Apr 18, 2017·Journal of Pharmaceutical Sciences·Kazuaki TaguchiMasaki Otagiri
Mar 9, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Timothy N Estep
Oct 18, 2008·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Jianqun HanRuijuan Xiu
Jan 10, 2009·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Tao LiChengmin Yang
Jan 12, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Maaike Te Lintel HekkertDirk J Duncker
Jul 6, 2010·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Zhen YouYong Zeng
Mar 20, 2010·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Tao LiChengmin Yang
Jul 30, 2017·Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs·Toru Hyakutake, Takumi Kishimoto
Dec 15, 2019·Seminars in Hematology·Timothy N Estep
Sep 21, 2021·Cardiovascular Toxicology·Alireza JenabiMurugan Ramalingam
Apr 4, 2009·Critical Care Clinics·Jacques Creteur, Jean-Louis Vincent

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.